Learn more about Hemanext to envision a world with fewer, better transfusions.
Who We Are
Hemanext is a medical technology company with corporate headquarters in Lexington, MA and manufacturing operations in Avon, MA. Our corporate mission is to support the transfusion medicine community in its efforts to save lives and improve patient outcomes. Our distinctive focus is on innovations that promote dramatic improvements in transfusion therapy.
Learn about the journey of red blood cells after donation including degradation that occurs during storage and discover the potential of hypoxic storage to alleviate this problem.
The average human body stores about 5.6 liters of blood. As it circulates through the body several times each minute, it accomplishes a variety of functions.
The existence of the storage lesion process has been well established, and recent scientific work has increased the precision and depth.
Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction13, and mortality14.
Hemanext is developing a technology to enable the storage of RBC under hypoxic conditions. Removing O2 during storage removes the primary “fuel” for oxidative stress1-11.